跳至主要内容
临床试验/NL-OMON55056
NL-OMON55056已完成4 期

Heavy menstrual bleeding in premenopausal women treated with direct oral anticoagulants - a randomised controlled trial. - MEDEA

Academisch Medisch Centrum0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - premenopausal women
  • - age *18 years
  • - anticoagulant treatment with a factor Xa inhibitor
  • - indication for anticoagulant treatment >3months after inclusion
  • - heavy menstrual bleeding and a PBAC-score >150
  • - use of adequate contraceptive methods during study participation (this is
  • advised to any woman on factor Xa inhibitors during fertile ages, regardless of
  • study participation)

排除标准

  • - PBAC-score *150
  • - postmenopausal women; women >12 consecutive months of spontaneous amenorrhea
  • - concomitant use of hormonal therapy as a new intervention for HMB
  • - pregnancy or currently planning for pregnancy
  • - active malignancy or treatment with chemotherapy/radiotherapy
  • - cervical preneoplastic lesions
  • - contra indication for the registered products dabigatran or tranexamic acid
  • - any condition that, as judged by investigator, would place the subject at an
  • increased risk of harm if she participated in the study

研究者

相似试验